bone disease therapy (OsteoQC/OsteoGeneX)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namebone disease therapy (OsteoQC/OsteoGeneX)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBone synthesis stimulants
TargetsUpdating
Therapy Area/IndicationsBone Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOsteoGeneX Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOsteoQCOsteoGeneX Inc
Active IndicationsN/A
Inactive IndicationsBone Diseases

Other Information

ATC CodeN/A
Related LinksN/A